Biotech firm Eurofins raises €299m to finance further M&A
European laboratory testing firm Eurofins secured €299m of capital to support its acquisition strategy, through an accelerated bookbuild run by Jefferies and Berenberg on Monday night.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts